Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03989115
Brief Title: Dose-Escalation/Expansion of RMC-4630 and Cobimetinib in Relapsed/Refractory Solid Tumors and RMC-4630 and Osimertinib in EGFR Positive Locally Advanced/Metastatic NSCLC

First Submitted : June 14, 2019
First Submitted that Met QC Criteria : June 14, 2019
First Posted : June 18, 2019

Last Update Submitted that Met QC Criteria : August 31, 2021
Last Update Posted : September 1, 2021